NCT00917358View on ClinicalTrials.gov

Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hepatitis C
Interventions
DRUG

Pegylated interferon alfa-2a

Pegylated interferon alfa-2a 135 ug/week for 24 weeks

Trial Locations (5)

10002

National Taiwan University Hospital, Taipei

Unknown

Buddhist Tzu Chi General Hospital, Chiayi City

Chiayi Christian Hospital, Chiayi City

National Taiwan University Hospital, Yun-Lin Branch, Douliu

Far Eastern Memorial Hospital, Taipei

All Listed Sponsors
collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

National Taiwan University Hospital

OTHER

NCT00917358 - Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C | Biotech Hunter | Biotech Hunter